Cila Therapeutics
Jeanine D'Armiento is on the Board of Advisors at Cila Therapeutics. Jeanine is also a Director of the Center for LAM and Rare Lung Disease at Columbia University Medical Center.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Cila Therapeutics
Cila Therapeutics is a clinic-ready stage, a biotechnology company developing new inhaled therapies for respiratory diseases, leading with an inhaled treatment of a rare genetic disorder, Primary Ciliary Dyskinesia, or PCD.